Disc Medicine, Inc.
IRON
$59.79
$0.3750.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 45.20M | 37.47M | 33.05M | 30.45M | 26.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 168.76M | 138.20M | 129.72M | 124.88M | 110.99M |
| Operating Income | -168.76M | -138.20M | -129.72M | -124.88M | -110.99M |
| Income Before Tax | -144.93M | -116.02M | -109.00M | -103.27M | -90.89M |
| Income Tax Expenses | 461.00K | 469.00K | 355.00K | 211.00K | 117.00K |
| Earnings from Continuing Operations | -145.39 | -116.49 | -109.36 | -103.48 | -91.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -145.39M | -116.49M | -109.36M | -103.48M | -91.00M |
| EBIT | -168.76M | -138.20M | -129.72M | -124.88M | -110.99M |
| EBITDA | -168.64M | -138.05M | -129.56M | -124.71M | -110.80M |
| EPS Basic | -4.47 | -3.92 | -3.98 | -3.97 | -3.66 |
| Normalized Basic EPS | -2.79 | -2.44 | -2.48 | -2.51 | -2.32 |
| EPS Diluted | -4.47 | -3.92 | -3.98 | -3.97 | -3.66 |
| Normalized Diluted EPS | -2.79 | -2.44 | -2.48 | -2.51 | -2.32 |
| Average Basic Shares Outstanding | 128.28M | 118.90M | 110.39M | 104.84M | 99.22M |
| Average Diluted Shares Outstanding | 128.28M | 118.90M | 110.39M | 104.84M | 99.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |